Related Articles for PubMed (Select 16867188)

Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.

Eckert L, Lançon C.

BMC Psychiatry. 2006 Jul 24;6:30. Review.

PMID: 16867188 [PubMed - indexed for MEDLINE]

Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.

Vis PM, van Baardewijk M, Einarson TR.

Ann Pharmacother. 2005 Nov;39(11):1798-807. Epub 2005 Sep 27.

PMID: 16189284 [PubMed - indexed for MEDLINE]

Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.

Eckert L, Falissard B.

Curr Med Res Opin. 2006 Nov;22(11):2313-21.

PMID: 17076991 [PubMed - indexed for MEDLINE]

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.

Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.

J Psychiatr Res. 2008 Jan;42(1):22-34. Epub 2007 Apr 18.

PMID: 17445831 [PubMed - indexed for MEDLINE]

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.

Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. Epub 2009 Jan 22.

PMID: 19165525 [PubMed - indexed for MEDLINE]

Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.

Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J.

Clin Ther. 2004 Sep;26(9):1446-55.

PMID: 15531007 [PubMed - indexed for MEDLINE]

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID: 16172440 [PubMed - indexed for MEDLINE]

Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder.

van Baardewijk M, Vis PM, Einarson TR.

Curr Med Res Opin. 2005 Aug;21(8):1271-9.

PMID: 16083537 [PubMed - indexed for MEDLINE]

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M.

Neuropsychobiology. 2007;56(2-3):73-85. Epub 2007 Nov 23.

PMID: 18037817 [PubMed - indexed for MEDLINE]

10:

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

Shelton C, Entsuah R, Padmanabhan SK, Vinall PE.

Int Clin Psychopharmacol. 2005 Jul;20(4):233-8.

PMID: 15933485 [PubMed - indexed for MEDLINE]

11:

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.

Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.

Curr Med Res Opin. 2007 Jun;23(6):1303-18. Epub 2007 Apr 27.

PMID: 17559729 [PubMed - indexed for MEDLINE]

12:

Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.

Einarson TR, Arikian SR, Casciano J, Doyle JJ.

Clin Ther. 1999 Feb;21(2):296-308.

PMID: 10211533 [PubMed - indexed for MEDLINE]

13:

Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

Khandker RK, Kruzikas DT, McLaughlin TP.

J Manag Care Pharm. 2008 Jun;14(5):426-41.

PMID: 18597572 [PubMed - indexed for MEDLINE]

14:

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.

Thase ME, Pritchett YL, Ossanna MJ, Swindle RW, Xu J, Detke MJ.

J Clin Psychopharmacol. 2007 Dec;27(6):672-6.

PMID: 18004135 [PubMed - indexed for MEDLINE]

15:

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID: 17563128 [PubMed - indexed for MEDLINE]

16:

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball SG, Russell JM.

J Psychopharmacol. 2008 Jun;22(4):417-25.

PMID: 18635722 [PubMed - indexed for MEDLINE]

17:

Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.

Lenox-Smith A, Greenstreet L, Burslem K, Knight C.

Clin Drug Investig. 2009;29(3):173-84. doi: 10.2165/00044011-200929030-00004.

PMID: 19243210 [PubMed - indexed for MEDLINE]

18:

Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.

Stewart DE, Wohlreich MM, Mallinckrodt CH, Watkin JG, Kornstein SG.

J Affect Disord. 2006 Aug;94(1-3):183-9. Epub 2006 Jun 14.

PMID: 16780958 [PubMed - indexed for MEDLINE]

19:

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.

Beasley CM Jr, Koke SC, Nilsson ME, Gonzales JS.

Clin Ther. 2000 Nov;22(11):1319-30.

PMID: 11117656 [PubMed - indexed for MEDLINE]

20:

Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.

Hunziker ME, Suehs BT, Bettinger TL, Crismon ML.

Clin Ther. 2005 Aug;27(8):1126-43. Review.

PMID: 16199241 [PubMed - indexed for MEDLINE]

Recent Activity